- TWD2.95bn
- TWD3.85bn
- TWD3.41bn
- 59
- 37
- 39
- 39
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7,794 | 3,378 | 2,098 | 2,777 | 3,414 |
Cost of Revenue | |||||
Gross Profit | 1,770 | 657 | 318 | 458 | 479 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 7,827 | 3,453 | 1,988 | 2,694 | 3,257 |
Operating Profit | -32.6 | -74.9 | 110 | 82.7 | 157 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 198 | -165 | 99.6 | 108 | 141 |
Provision for Income Taxes | |||||
Net Income After Taxes | 121 | -181 | 106 | 99.5 | 80.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 326 | -146 | 106 | 99.5 | 80.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 327 | -146 | 109 | 107 | 82.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.09 | -2.07 | 0.181 | 1.12 | 0.727 |
Dividends per Share |